Newtyn Management’s Wave Life Sciences WVE Stock Holding History

Newtyn Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Sell	215,000 -85,000	-28%	-$564K	0.16%	32
2026 Q1	$2.17M	Hold	300,000	–	–	0.23%	29
2025 Q4	$5.1M	Hold	300,000	–	–	0.54%	29
2025 Q3	$2.2M	Sell	300,000 -100,000	-25%	-$809K	0.27%	30
2025 Q2	$2.6M	Hold	400,000	–	–	0.39%	31
2025 Q1	$3.23M	Sell	400,000 -25,000	-6%	-$273K	0.51%	25
2024 Q4	$5.26M	Hold	425,000	–	–	0.92%	27
2024 Q3	$3.48M	Sell	425,000 -50,000	-11%	-$299K	0.53%	29
2024 Q2	$2.37M	Sell	475,000 -25,000	-5%	-$143K	0.45%	27
2024 Q1	$3.08M	Sell	500,000 -10,000	-2%	-$50.1K	0.61%	26
2023 Q4	$2.58M	Hold	510,000	–	–	0.51%	31
2023 Q3	$2.93M	Buy	510,000 +10,000	+2%	+$45.7K	0.72%	28
2023 Q2	$1.82M	Sell	500,000 -14,028	-3%	-$56.7K	0.43%	31
2023 Q1	$2.23M	Sell	514,028 -85,972	-14%	-$394K	0.44%	46
2022 Q4	$4.2M	Hold	600,000	–	–	0.87%	31
2022 Q3	$2.17M	Buy	600,000 +196,447	+49%	+$650K	0.48%	39
2022 Q2	$1.31M	Buy	+403,553	New	+$776K	0.25%	54

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Newtyn Management's WVE Position: Q2 2026 in Review

Newtyn Management reduced its Wave Life Sciences (WVE) stake by 28% in Q2 2026, selling an estimated $564K and leaving 215,000 shares worth $1.25M. The position accounts for 0.16% of the portfolio, ranked #32.

Newtyn Management first reported a position in WVE in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.26M in Q4 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Newtyn Management held 215,000 shares of Wave Life Sciences worth $1.25M as of Q2 2026.
Newtyn Management sold 85,000 Wave Life Sciences shares in Q2 2026, an estimated $564K.
Wave Life Sciences made up 0.16% of Newtyn Management's portfolio in Q2 2026, its #32 holding.
Newtyn Management first reported a position in Wave Life Sciences in Q2 2022 and has held it in 17 quarters since.
Newtyn Management's Wave Life Sciences position peaked at $5.26M in Q4 2024.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Newtyn Management's 13F filing for Q2 2026, filed 14 Aug 2026.